Skip to main content

Brain Microvascular Endothelial Cell Derived Exosomes Potently Ameliorate Cognitive Dysfunction by Enhancing the Clearance of Aβ Through Up-Regulation of P-gp in Mouse Model of AD

Abstract

Accumulation of amyloid-β (Aβ) peptides in the brain is regarded as a major contributor to the pathogenesis and progression of Alzheimer's disease (AD). P-glycoprotein (P-gp) as a member of ABC transporter family situated in blood brain barrier (BBB) plays a role on cleaning of Aβ via its efflux transport effect in the treatment of AD. However, the expression of P-gp in pathological BBB was lower than that in normal BBB, thus impeding the clearance of Aβ. Here, we used human brain microvascular endothelial cells (HBMVECs) derived exosomes (HBMVECs-Ex) inheriting P-gp as an extracorporeal Aβ cleansing system to remove Aβ peptides from the brain by specific capture between P-gp and Aβ. The results showed that HBMVECs-Ex inheriting P-gp greatly facilitated the cerebral clearance of Aβ by effectively transporting Aβ out of brain and potently ameliorated cognitive dysfunction in AD mice. Taken together, HBMVECs-Ex provided a new strategy on the treatment of AD.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

References

  1. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ et al (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropath Exp Neurol 71:362–381

    Article  Google Scholar 

  2. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8:499–509

    CAS  Article  Google Scholar 

  3. Lee SJC, Nam E, Lee HJ, Savelieff MG, Lim MH (2017) Towards an understanding of amyloid-beta oligomers: characterization, toxicity mechanisms, and inhibitors. Chem Soc Rev 46:310–323

    CAS  Article  Google Scholar 

  4. Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698–712

    CAS  Article  Google Scholar 

  5. Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer’s neurodegeneration. Trends Neurosci 28:202–208

    CAS  Article  Google Scholar 

  6. Madadi S, Schwarzenbach H, Saidijam M, Mahjub R, Soleimani M (2019) Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease. Cell Biosci 9:91

    Article  Google Scholar 

  7. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B et al (2000) Clearance of Alzheimer’s amyloid-β 1–40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier. J Clin Invest 106(12):1489–1499

    CAS  Article  Google Scholar 

  8. Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, Kim KS et al (1998) Human blood-brain barrier receptors for Alzheimer’s amyloid-beta 1–40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 102(4):734–743

    CAS  Article  Google Scholar 

  9. Selkoe DJ (2004) American College of Physicians and American Physiological Society, Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 140:627–638

    CAS  Article  Google Scholar 

  10. Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ et al (2001) Beta-amyloid efflux mediated by p-glycoprotein. J Neurochem 76:1121–1128

    CAS  Article  Google Scholar 

  11. Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I et al (2007) MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides—implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol 17:347–353

    CAS  Article  Google Scholar 

  12. Calabrese V, Stella AM, Butterfield DA, Scapagnini G (2004) Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. Antioxid Redox Signal 6:895–913

    CAS  PubMed  Google Scholar 

  13. Brenn A, Grube M, Peters M, Fischer A, Jedlitschky G, Kroemer HK et al (2011) beta-Amyloid downregulates MDR1-P-glycoprotein (Abcb1) expression at the blood-brain barrier in mice. Int J Alzheimers Dis 2011:690121

    PubMed  PubMed Central  Google Scholar 

  14. Shubbar MH, Penny JI (2018) Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells. Biochim Biophys Acta Gen Subj 1862:2314–2322

    CAS  Article  Google Scholar 

  15. Hartz AM, Miller DS, Bauer B (2010) Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol Pharmacol 77:715–723

    CAS  Article  Google Scholar 

  16. Qosa H, Batarseh YS, Mohyeldin MM, El Sayed KA, Keller JN, Kaddoumi A (2015) Oleocanthal enhances amyloid-beta clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model. ACS Chem Neurosci 6:1849–1859

    CAS  Article  Google Scholar 

  17. Brenn A, Grube M, Jedlitschky G, Fischer A, Strohmeier B, Eiden M et al (2014) St. John’s Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer's disease mouse model-role of P-glycoprotein. Brain Pathol 24:18–24

    Article  Google Scholar 

  18. Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M (2014) A comprehensive overview of exosomes as drug delivery vehicles—endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta 1846:75–87

    CAS  PubMed  Google Scholar 

  19. Cui GH, Guo HD, Li H, Zhai Y, Gong ZB, Wu J et al (2019) RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease. Immun Ageing 16:10

    Article  Google Scholar 

  20. Zheng Y, He R, Wang P, Shi Y, Zhao L, Liang J (2019) Exosomes from LPS-stimulated macrophages induce neuroprotection and functional improvement after ischemic stroke by modulating microglial polarization. Biomater Sci 7:2037–2049

    CAS  Article  Google Scholar 

  21. Wang H, Sui H, Zheng Y, Jiang Y, Shi Y, Liang J et al (2019) Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3beta pathway. Nanoscale 11:7481–7496

    CAS  Article  Google Scholar 

  22. Yang J, Zhang X, Chen X, Wang L, Yang G (2017) Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids 7:278–287

    CAS  Article  Google Scholar 

  23. Zhao L, Li H, Shi Y, Wang G, Liu L, Su C et al (2015) Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78. Int J Nanomedicine 10:245–256

    PubMed  Google Scholar 

  24. Lim HS, Kim YJ, Sohn E, Yoon J, Kim BY, Jeong SJ (2018) Bojungikgi-tang, a traditional herbal formula, exerts neuroprotective effects and ameliorates memory impairments in Alzheimer’s disease-like experimental models. Nutrients 10:1952

    Article  Google Scholar 

  25. Zhang X, Wang X, Hu X, Chu X, Li X, Han F (2019) Neuroprotective effects of a Rhodiola crenulata extract on amyloid-beta peptides (Abeta1-42)-induced cognitive deficits in rat models of Alzheimer's disease. Phytomedicine 57:331–338

    CAS  Article  Google Scholar 

  26. Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848–858

    Article  Google Scholar 

  27. Sahay G, Alakhova DY, Kabanov AV (2010) Endocytosis of nanomedicines. J Control Release 145:182–195

    CAS  Article  Google Scholar 

  28. Sahay G, Kim JO, Kabanov AV, Bronich TK (2010) The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. Biomaterials 31:923–933

    CAS  Article  Google Scholar 

  29. Provias J, Jeynes B (2014) The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer's disease. Int J Alzheimers Dis 2014:191863

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Park R, Kook SY, Park JC, Mook-Jung I (2014) Abeta1–42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-kappaB signaling. Cell Death Dis 5:e1299

    CAS  Article  Google Scholar 

  31. Reza-Zaldivar EE, Hernández-Sapiéns MA, Minjarez B, Gutiérrez-Mercado YK, Márquez-Aguirre AL, Canales-Aguirre AA (2018) Potential effects of MSC-derived exosomes in neuroplasticity in Alzheimer’s disease. Front Cell Neurosci 12:317

    CAS  Article  Google Scholar 

  32. Iranifar E, Seresht BM, Momeni F, Fadaei E, Mehr MH, Ebrahimi Z, Rahmati M, Kharazinejad E, Mirzaei H (2019) Exosomes and microRNAs: new potential therapeutic candidates in alzheimer disease therapy. J Cell Physiol 234:2296–2305

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was supported by Scientific Research Project of Liaoning Provincial Department of Education (JYTQN201719) and Natural Science Foundation of Liaoning Province (2019-ZD-0808). We thank the support of the above funds.

Author information

Affiliations

Authors

Contributions

JP performed all experiments and wrote the manuscript; RH and QH helped with the animal experiments and biological study; YS and LZ conducted and supervised the whole experiments. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Yijie Shi or Liang Zhao.

Ethics declarations

Conflict of interest

The authors report no conflicts of interest in this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pan, J., He, R., Huo, Q. et al. Brain Microvascular Endothelial Cell Derived Exosomes Potently Ameliorate Cognitive Dysfunction by Enhancing the Clearance of Aβ Through Up-Regulation of P-gp in Mouse Model of AD. Neurochem Res 45, 2161–2172 (2020). https://doi.org/10.1007/s11064-020-03076-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-020-03076-1

Keywords

  • Amyloid-β
  • Alzheimer’s disease
  • P-glycoprotein
  • Blood–brain barrier
  • HBMVECs-Ex